Transcript NPCR provides national leadership to Cancer Registries

Quality
Cancer Data
Saves Lives
The Vital Role of Cancer Registrars
in the Fight against Cancer
18 Million
1.5 million
67%
Cancer Registries



Statistics
Treatment strategies
Public health initiatives
Goal
The ultimate goal of
collecting cancer
information is to prevent
and control cancer and
improve patient care
Result
Assist physicians in
assessing the efficacy of
diagnostic and
therapeutic methods
Result
Aid in the decision making
about unmet needs,
physician recruitment,
space needs, resource
allocation, and health
planning
Result
Respond to local needs
through an assessment of
referral patterns, cancer
trends, and development
opportunities
Cancer Registries
collect a wide range of
cancer-related
information; including —
 Demographics
Cancer-related Information



Medical history
Diagnosis and
prognosis
indicators
Treatment
patterns




Cancer
recurrence
Survival rates
Health care
coverage
Patient eligibility
Different Kinds of
Cancer Registries
Health care providers record patient
information and diagnosis
Hospital-based cancer registrar
abstracts patient information into
uniform data sets and checks for an
existing record for each patient
Patient data is aggregated on a
state level, and then sent to national
registries (SEER or NPCR)
Hospital Cancer Registry
State Cancer Registry
National Center for Health
Statistics
Cancer mortality comes
from State Health Depts.
to the CDC’s NCHS
Surveillance Epidemiology and
End Results Program (SEER)
http://seer.cancer.gov/
National Program
of Cancer Registries
Today, NPCR
and SEER
registries work
collaboratively to
collect and report
cancer statistics
on the entire U.S.
population.
http://www.cdc.gov/cancer/
npcr/uscs/
NPCR provides national leadership
to Cancer Registries
NAACCR Certified
State Registries 2011
•
•
•
Gold
Silver
Black-
did not meet
certification requirements
NPCR is expanding efforts to
improve and use cancer data by:
Providing technical
assistance to registries
to help ensure data
completeness,
timeliness, and quality
Coordinating and convening
meetings of registry
personnel for information
sharing, problem solving,
and training
Helping states and national
organizations use cancer data
to describe state and national
disease burdens, evaluate
cancer control activities, and
identify populations at risk for
certain cancers
Collaborating with federal,
state, and private
organizations to design and
conduct research using data
collected through state
registries
CDC: National Standards

CDC has
established
national
standards to
ensure the
completeness,
timeliness, and
quality of
Cancer Registry
data
National Cancer Data Base
http://www.facs.org/cancer/
ncdb/index.html
International
Association of
Cancer Registries
How Registries Collect
Cancer Data
The techniques
used by Cancer
Registrars allow
for uniform data
collection
http://www.naaccr.org/
Standard setting
organizations
provide guidance
and direction to the
Cancer Registrar
Last Name:
Place of Birth:
Soc Sec #:
Span/Hisp Orig:
Doe
25
123-45-6789
0
PATIENT INFORMATION
Jane
Middle Name:
4111946
Age:
2
Race:
21
Primary Payer:
Sue
58
1
10
Facility ID#:
Med Rec #:
Date Last Contact:
Cancer Status:
4749421
3344221
11152004
1
Address at Diagnosis:
58
42790
Physicians:
Jones
Johnson
Class of Case:
Seq No:
Date 1st Contact:
Year 1st Seen:
Fac Ref From:
Fac Ref To:
Reg LN Exam:
Reg LN Pos:
1
Jones
Smith
King
Other: ___________________
CANCER INFORMATION & DIAGNOSIS
5012004
Primary Site Text:
R Breast UOQ
Prim Site Code: C50.4
Comorb/Comp 1:
Comorb/Comp 2:
Comorb/Comp 3:
Comorb/Comp 4:
Comorb/Comp 5:
Comorb/Comp 6:
Laterality:
1
Grade:
Dx Conf:
SS2000:
2
1
1
4282004
2004
6
0
First Name:
Date of Birth:
Sex:
County (Dx):
Date Init Dx:
Accn #:
AJCC STAGE
Clin: T1N1M0
IIA
Path: T1N0M0
IA
Histology Text:
Infiltrating Duct Carcinoma
Hist/Behav Code: 85003
Tumor Size:
TEXT
Physical Exam:
Surg Diag/Stag Proc:
Papable mass in right breast and suspicous r axillary lymph node on exam.
Patient scheduled for biopsy
Lab Tests:
ERA/PRA positive
Pathology:
Approx. 1.5 cm mass that is mostly intraductal carcinoma with an area 9mm of
invasive infiltrating duct carcinoma. Two sentinel nodes and four axillary nodes
are negative for carcinoma.
Scopes:
Op Proc:
, intraductal carcinoma, 05/04/2004 reexcision intraductal and a foci of
invasive infiltrating duct. Right axillary lymph node dissection
9
TREATMENT
2
Date Surg Diag/Stag:
5012004
Date 1st Crs Rx:
Surg Prim Site:
Surg Marg:
Surg Proc Other Site:
5042001
23
0
0
Date 1st Surg Proc:
Date Most Defin Surg:
Scope Reg LN Surg:
Reason No Surg:
5012004
5042001
6
0
Date RT Started:
Reg RT Tx Modality:
Rad/Surg Seq:
6152004
27
3
Date RT Ended:
Reg RT Dose cGy:
Reason No RT:
7302004
6500
0
Date Sys Tx Started:
Palliative Proc:
8052004
0
Date Oth Ther Started:
Staging:
Path 9mm invasion, no positive nodes, localized
Place of Dx:
TREATMENT TEXT
A patient’s file or
abstract, contains
many different
sections and fields
Surgery:
Memorial Hospital
X-Rays/Scans:
Lumpectomy with node dissection
Radiation:
post op rads
Chemotherapy:
04/28/2004 new spiculated mass
Remarks:
Hormone/Steroid:
Immunotherapy:
Transplant/Endocrine:
Other Therapy:
none recommended
Tamoxifen
Abstracting
Abstracting is converting
a patient’s medical
information to uniform
cancer data
Electronic
Medical
Records
Last Name:
Place of Birth:
Soc Sec #:
Span/Hisp Orig:
Doe
25
123-45-6789
0
PATIENT INFORMATION
Jane
Middle Name:
4111946
Age:
2
Race:
21
Primary Payer:
First Name:
Date of Birth:
Sex:
County (Dx):
Address at Diagnosis:
Physicians:
Jones
Johnson
Class of Case:
Seq No:
Date 1st Contact:
Year 1st Seen:
Fac Ref From:
Fac Ref To:
Reg LN Exam:
Reg LN Pos:
1
4282004
2004
6
0
Date Init Dx:
Accn #:
AJCC STAGE
Clin: T1N1M0
IIA
Path: T1N0M0
IA
4749421
3344221
11152004
1
58
Comorb/Comp 1:
Comorb/Comp 2:
Comorb/Comp 3:
Comorb/Comp 4:
Comorb/Comp 5:
Comorb/Comp 6:
42790
Laterality:
1
Grade:
Dx Conf:
SS2000:
2
1
1
Histology Text:
Infiltrating Duct Carcinoma
Hist/Behav Code: 85003
Tumor Size:
TEXT
Surg Diag/Stag Proc:
Papable mass in right breast and suspicous r axillary lymph node on exam.
Patient scheduled for biopsy
Lab Tests:
ERA/PRA positive
Approx. 1.5 cm mass that is mostly intraductal carcinoma with an area 9mm of
invasive infiltrating duct carcinoma. Two sentinel nodes and four axillary nodes
are negative for carcinoma.
Scopes:
Op Proc:
Facility ID#:
Med Rec #:
Date Last Contact:
Cancer Status:
Jones
Smith
King
Other: ___________________
CANCER INFORMATION & DIAGNOSIS
5012004
Primary Site Text:
R Breast UOQ
Prim Site Code: C50.4
Physical Exam:
Pathology:
Sue
58
1
10
, intraductal carcinoma, 05/04/2004 reexcision intraductal and a foci of
invasive infiltrating duct. Right axillary lymph node dissection
9
TREATMENT
2
Date Surg Diag/Stag:
5012004
Date 1st Crs Rx:
Surg Prim Site:
Surg Marg:
Surg Proc Other Site:
5042001
23
0
0
Date 1st Surg Proc:
Date Most Defin Surg:
Scope Reg LN Surg:
Reason No Surg:
5012004
5042001
6
0
Date RT Started:
Reg RT Tx Modality:
Rad/Surg Seq:
6152004
27
3
Date RT Ended:
Reg RT Dose cGy:
Reason No RT:
7302004
6500
0
Date Sys Tx Started:
Palliative Proc:
8052004
0
Date Oth Ther Started:
Staging:
Path 9mm invasion, no positive nodes, localized
Place of Dx:
TREATMENT TEXT
Surgery:
Memorial Hospital
X-Rays/Scans:
Lumpectomy with node dissection
Radiation:
post op rads
Chemotherapy:
04/28/2004 new spiculated mass
Remarks:
Hormone/Steroid:
Immunotherapy:
Transplant/Endocrine:
Other Therapy:
none recommended
Tamoxifen
Cancer
Registries have
embraced
technology
Cancer Registries exist
within a national
framework of health
monitoring and data
collection
The Flow of
Cancer
Information:
A Case Study
Diagnosis to treatment

Jane Smith learns
from her internist
that she likely
has breast cancer
Diagnosis to treatment

Further tests
are completed
at the hospital
Diagnosis to treatment

Jane’s doctor
proposes a
course of
treatment
Diagnosis to treatment

Follow-up tests
show Jane to be
cancer free
Diagnosis to treatment

Jane’s data is added
to other SEER and
Michigan central
Cancer Registry
data, and the
National Cancer
Data Base, where it
will go through more
quality processes
and refinement
Diagnosis to treatment

The Cancer
Registrar will
regularly followup
Cancer Information is Used
to Improve Prevention,
Research, and Care
Cancer information is used in
thousands of ways, including —
Evaluate patient
outcome, quality of life,
and satisfaction issues
and implement
procedures for
improvement
Evaluate
efficacy of
treatment
modalities
Provide
outcome
information
for cancer
surveillance
http://www.cdc.gov/cancer/
npcr/uscs/
Report cancer incidence as
required by state and federal
laws
http://www.ccrcal.org/pdf/
Reports/Physicians.pdf
Trends in Five-Year Relative Survival Rates
Estimated Numbers of US Cancer Survivors by Sex
and Time Since Diagnosis as of January 1, 2012
Male
Female
Time since
diagnosis
Number
Percent
Cummulative
Percent
Number
Percent
0 to <5 years
2,608,320
40%
40%
2,339,950
32%
32%
5 to <10 years
1,628,010
25%
65%
1,595,410
22%
54%
10 to <15 years
997,060
15%
80%
1,135,160
16%
70%
15 to <20 years
570,290
9%
89%
791,880
11%
81%
20 to <25 years
305,140
5%
94%
536,670
7%
88%
25 to <30 years
154,470
2%
96%
343,300
5%
92%
30+ years
179,010
3%
100%
499,210
7%
100%
Note: Percentages may not sum to 100% due to rounding.
Source: Data Modeling Branch, Division of Cancer Control and Population Sciences, National
Cancer Institute.
Cummulative
Percent
Calculate survival
rates by various
data items, such
as sex, race, and
age
Provide information
for cancer
prevention
activities
Analyze referral
patterns
Allocate resources
at local, state, and
national levels
Develop educational programs for
health care providers, patients,
and the general public
Cancer data form much of
the body of knowledge used
by medical professionals,
epidemiologists,
policymakers, and public
health officials
Kentucky
Thousands of lives were
saved in Kentucky
through early detection
of breast cancer
Minnesota
In Minnesota, a rare type
cancer caused by
asbestos exposure was
identified, leading the
state to look for
increased state funding
for occupational-related
disease
New York
Cancer registry data are
now used to educate
New Yorkers about
cancer risk factors
Cancer Registrars Ensure
Accuracy and Privacy
Inaccurate data is
useless, expensive,
and often harmful
Health care providers record patient
information and diagnosis
Hospital-based cancer registrar
abstracts patient information into
uniform data sets and checks for an
existing record for each patient
National data
is only as good
as state and
local data
Patient data is aggregated on a
state level, and then sent to national
registries (SEER or NPCR)
Privacy concerns are
paramount to Cancer
Registrars
High quality
data results
from trained
specialists:
Cancer
Registrars
Cancer Registrars not only
record data, they find and
interpret it
The Cancer Registrar must
have comprehensive
knowledge about cancer
diagnoses, treatment, and
information management
The Cancer Registrar is
a key member of health
care team
Education for Health
Information Management
Professionals and Cancer
Registrars are similar
Hospital-based Registrar’s Role
Goes Beyond Data Collection
Cancer Program Management
 Cancer Committee Member
 Monitor quality of Cancer Program
Management
 Provide benchmarks for quality
comparison

Hospital-based Registrar’s Role
Goes Beyond Data Collection



Data Analysis for Studies
Compiling Cancer Program Annual
Report
Assess referral patterns
Hospital-based Registrar’s Role
Goes Beyond Data Collection


Participate in cancer prevention
Present information to cancer
committee, physicians,
administration
Registrars in Central Cancer
Registries are Key Players in
Insuring Quality Health Care
Edit the data from all facilities
 Query the database for data quality
reports
 Merge duplicate records
 Audit healthcare facilities to insure
accurate, timely, complete data

Registrars in Central Cancer
Registries are Key Players in
Ensuring Quality Health Care
Work with researchers
 Contribute to data analysis for
cancer program planning
 Present data to the local
community, schools, and others
 Provide education and training
for registrars

How Does One Become a
Cancer Registrar?
Formal Education
Programs Produce
Excellent Cancer
Registrars
CTRs have
pursued
higher
education
0
PhD or
Masters
Some college,
associates,
bachelors
Cancer Registrars:
A challenging career
requires quality education,
and certification
Certification of
Cancer Registrars
Certification ensures
quality results
Additional benefits: certification
Establishing a standard of
knowledge and competence
 Measuring the requisite
knowledge, skills and abilities of
CTR® applicants
 Promoting professional growth
and individual study
 Formally recognizing CTRs who
meet recertification requirements

NCRA’s Certification
Examination
In 1983, the National Tumor
Registrars Association (now
NCRA) administered the first
certification examination for
tumor registry professionals.
NCRA: Resources for
Registrars
NCRA represents
Cancer Registry
professionals and CTRs
NCRA Mission Statement

Serve as the premier
education, credentialing
and advocacy resource for
cancer data professionals.
NCRA offers:



Multiple educational
and networking opportunities
Annual national conference to
build knowledge and expertise
Promotion of professional
standards and ethics
NCRA offers:


Management of the
CTR process and
NCRA’s Council on
Certification
Publication of a peerreviewed scientific
journal and a
quarterly newsletter
NCRA offers:
A Web site
offering a wide
range of
publications
and information about
educational opportunities
 http://www.ncra-usa.org*

Cancer Registry is a
Dynamic Profession
Cancer Registry
is a dynamic
profession


Registrars are
dedicated, enthusiastic,
and self motivated
professionals
Registrars work closely
with physicians and
administrators
Cancer Registry
is a dynamic
profession


Registry data make
a difference in
patient care and
cancer research
Registrars perform a
wide variety of interesting
tasks, including data analysis
Cancer Registry
is a dynamic
profession


The profession
offers regular work
day hours with holidays
and vacations
There is minimal
supervision required for
self motivated registrars
Cancer Registry careers
are rewarding
Masters Degree
$55,000
$39,000
Associates Degree
Cancer Registrars Have Many
Career Opportunities





Hospitals and Health Care
Facilities
Software Vendors
Government Agencies
Pharmaceutical Companies
Outsourcing or Contract
services
You and
Cancer Registries:
A Smart Choice
for a Bright Future